$AQST
Aquestive Therapeutics, Inc. Stock $aqst

$aqst Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000162828024045030 Filed on November 04, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$13.54M
YoY Change		4.15%
Cost Of Revenue		$4.437M
YoY Change		-7.52%
Gross Profit		$9.105M
YoY Change		10.98%
Gross Profit Margin		67.24%
Selling, General & Admin		$12.13M
YoY Change		64.2%
% of Gross Profit		133.18%
Research & Development		$5.269M
YoY Change		64.86%
% of Gross Profit		57.87%
Depreciation & Amortization		$159.0K
YoY Change		-27.06%
% of Gross Profit		1.75%
Operating Expenses		$17.40M
YoY Change		64.4%
Operating Profit		-$8.290M
YoY Change		248.76%
Interest Expense		-$1.801M
YoY Change		-243.39%
% of Operating Profit
Other Income/Expense, Net		-$1.418M
YoY Change
Pretax Income		-$11.51M
YoY Change		429.15%
Income Tax		$0.00
% Of Pretax Income
Net Earnings		-$11.51M
YoY Change		465.55%
Net Earnings / Revenue		-84.99%
Basic Earnings Per Share		-$0.13
Diluted Earnings Per Share		-$0.13
COMMON SHARES
Basic Shares Outstanding	91.18M shares	91.06M shares
Diluted Shares Outstanding		91.08M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$77.89M
YoY Change		212.57%
Cash & Equivalents		$77.89M
Short-Term Investments
Other Short-Term Assets		$1.972M
YoY Change		3.25%
Inventory		$7.021M
Prepaid Expenses
Receivables		$9.684M
Other Receivables		$0.00
Total Short-Term Assets		$96.57M
YoY Change		127.45%
LONG-TERM ASSETS
Property, Plant & Equipment		$3.848M
YoY Change		-15.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$4.230M
YoY Change		-22.44%
Total Long-Term Assets		$13.39M
YoY Change		-21.21%
TOTAL ASSETS
Total Short-Term Assets		$96.57M
Total Long-Term Assets		$13.39M
Total Assets		$110.0M
YoY Change		84.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$7.572M
YoY Change		-24.23%
Accrued Expenses		$5.025M
YoY Change		-8.1%
Deferred Revenue		$1.048M
YoY Change		-60.26%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$25.00K
YoY Change		-99.46%
Total Short-Term Liabilities		$15.15M
YoY Change		-37.02%
LONG-TERM LIABILITIES
Long-Term Debt		$31.25M
YoY Change		-9.57%
Other Long-Term Liabilities		$2.033M
YoY Change		1.09%
Total Long-Term Liabilities		$2.033M
YoY Change		1.09%
TOTAL LIABILITIES
Total Short-Term Liabilities		$15.15M
Total Long-Term Liabilities		$2.033M
Total Liabilities		$155.4M
YoY Change		-4.31%
SHAREHOLDERS EQUITY
Retained Earnings		-$346.2M
YoY Change		11.32%
Common Stock		$91.00K
YoY Change		35.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$45.42M
YoY Change
Total Liabilities & Shareholders Equity		$110.0M
YoY Change		84.97%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$11.51M
YoY Change		465.55%
Depreciation, Depletion And Amortization		$159.0K
YoY Change		-27.06%
Cash From Operating Activities		-$11.88M
YoY Change		405.53%
INVESTING ACTIVITIES
Capital Expenditures		$80.00K
YoY Change		-46.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$80.00K
YoY Change		-46.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-17.00K
YoY Change		-100.34%
NET CHANGE
Cash From Operating Activities		-11.88M
Cash From Investing Activities		-80.00K
Cash From Financing Activities		-17.00K
Net Change In Cash		-11.98M
YoY Change		-582.94%
FREE CASH FLOW
Cash From Operating Activities		-$11.88M
Capital Expenditures		$80.00K
Free Cash Flow		-$11.96M
YoY Change		378.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Local Phone Number LocalPhoneNumber	941-1900
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	AQST
	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23872000	usd
CY2023Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	8471000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4179000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5557000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1278000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5438000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	155378000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	300648000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-45420000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	109958000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7385000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34171000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	21832000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	15379000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	62886000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8290000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2377000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17192000	usd
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	us-gaap	Assets Current AssetsCurrent	40966000	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91178193	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91178193	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68533085	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	91000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346159000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13542000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45694000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4437000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4798000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13352000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5269000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3196000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15363000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12126000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4696000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8015000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	3177000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-3469000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2439000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24917000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2827000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	438000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5025000	usd
CY2023Q3	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	1514000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001398733
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	91178193	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77893000	usd
CY2024Q3	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	9684000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	96570000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3848000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5310000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4230000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	32345000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2033000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2016000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	163905000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68533085	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	69000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	212521000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-319077000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-106487000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57418000	usd
	dei	Entity Registrant Name EntityRegistrantName	Aquestive Therapeutics, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	30 Technology Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Warren
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3827296
	dei	City Area Code CityAreaCode	908
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	us-gaap	Inventory Net InventoryNet	7021000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6769000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1972000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1854000	usd
CY2024Q3	us-gaap	Assets Assets	109958000	usd
CY2023Q4	us-gaap	Assets Assets	57418000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7572000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8926000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5025000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6497000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	482000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	390000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1048000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1551000	usd
CY2024Q3	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	1000000	usd
CY2023Q4	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	922000	usd
CY2024Q3	us-gaap	Loans Payable Current LoansPayableCurrent	25000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	22000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	15152000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18308000	usd
CY2024Q3	aqst	Senior Notes Noncurrent And Finance Lease Liability Noncurrent SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent	31253000	usd
CY2023Q4	aqst	Senior Notes Noncurrent And Finance Lease Liability Noncurrent SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent	27508000	usd
CY2024Q3	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	18835000	usd
CY2023Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	14761000	usd
CY2024Q3	aqst	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized Noncurrent TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent	62730000	usd
CY2023Q4	aqst	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized Noncurrent TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent	63568000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5109000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	20266000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37377000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16152000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10216000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22200000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	48568000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11191000	usd
CY2024Q3	us-gaap	Royalty Expense RoyaltyExpense	1359000	usd
CY2023Q3	us-gaap	Royalty Expense RoyaltyExpense	0	usd
	us-gaap	Royalty Expense RoyaltyExpense	4075000	usd
	us-gaap	Royalty Expense RoyaltyExpense	0	usd
CY2024Q3	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	59000	usd
CY2023Q3	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	56000	usd
	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	2703000	usd
	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	16156000	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11509000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2175000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27082000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	385000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-140000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27082000	usd
	us-gaap	Net Income Loss NetIncomeLoss	241000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11509000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2035000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27082000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	241000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91082081	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64678761	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85224263	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59252768	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85224263	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61513736	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-106487000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1580000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-893000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	231400	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	539000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	539000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-12828000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-36301000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	46000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1523000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-5000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2745000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-35479000	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07059
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2780000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1256000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	8343000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4064000	usd
	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	175000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-353000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-11509000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5399000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1256000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	8343000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4064000	usd
	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	163000	usd
CY2024Q3	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	979000	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64678761	shares
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1577000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-202000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	193000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-11509000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-45420000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-118554000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	344000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-8000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	8068000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-109235000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	31000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	631000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91082081	shares
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1577000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-202000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	193000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-11509000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-45420000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-118554000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	344000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	8068000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-109235000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	31000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	631000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-3000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-3000	usd
CY2023Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000	usd
CY2023Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5792000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-106651000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-106651000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	774000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	774000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	625	shares
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	625	shares
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-102927000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-102927000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27082000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27082000	usd
	us-gaap	Net Income Loss NetIncomeLoss	241000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	571000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	571000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	878000	usd
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	300000	usd
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	300000	usd
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	usd
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1749000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1749000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	174000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-71000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	239000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1228000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1228000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	252000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	252000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1299000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1083000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1083000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1217000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	146000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2408000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-12582000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29270000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1438000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	144000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	979000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-144000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-979000	usd
	aqst	Proceeds From Issuance And Exercise Of Warrants ProceedsFromIssuanceAndExerciseOfWarrants	0	usd
	aqst	Proceeds From Issuance And Exercise Of Warrants ProceedsFromIssuanceAndExerciseOfWarrants	8342000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	31000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	732000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	18000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	12548000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1027000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1100000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83435000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	54021000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2356000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23872000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27273000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77893000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	305000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	5566000	usd
	aqst	Revenue From Contract With Customer Number Of Commercialized Products RevenueFromContractWithCustomerNumberOfCommercializedProducts	5	product
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77893000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346159000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	146000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2408000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-12582000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29270000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1438000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	144000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	979000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-144000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-979000	usd
	aqst	Proceeds From Issuance And Exercise Of Warrants ProceedsFromIssuanceAndExerciseOfWarrants	0	usd
	aqst	Proceeds From Issuance And Exercise Of Warrants ProceedsFromIssuanceAndExerciseOfWarrants	8342000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	30000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	31000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	732000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	18000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	12548000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1027000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83435000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	54021000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2356000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23872000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27273000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77893000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	305000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	aqst	Revenue From Contract With Customer Number Of Commercialized Products RevenueFromContractWithCustomerNumberOfCommercializedProducts	5	product
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77893000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346159000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	654000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1662000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	21314000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	488000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	715000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13542000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45694000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37377000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13542000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45694000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37377000	usd
CY2024Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	7715000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	5570000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1997000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2915000	usd
CY2024Q3	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	9684000	usd
CY2023Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	8471000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	654000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1662000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	21314000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	33896000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	488000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	715000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13542000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45694000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37377000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13542000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45694000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37377000	usd
CY2024Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	7715000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	5570000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1997000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2915000	usd
CY2024Q3	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	9684000	usd
CY2023Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	8471000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	3240000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2118000	usd
CY2024Q3	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	2731000	usd
CY2023Q4	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	3028000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1050000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1623000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	7021000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6769000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47206000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47063000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43358000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	3240000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2118000	usd
CY2024Q3	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	2731000	usd
CY2023Q4	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	3028000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1050000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1623000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	7021000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6769000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47206000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47063000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43358000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42884000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3848000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4179000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	159000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	218000	usd
	us-gaap	Depreciation Depreciation	493000	usd
	us-gaap	Depreciation Depreciation	760000	usd
CY2024Q3	aqst	Number Of Operating Leases NumberOfOperatingLeases	3	lease
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	457000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1345000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	123000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	349000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	438000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1308000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	109000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	338000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	317000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1284000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1318000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1346000	usd
CY2024Q3	aqst	Lessee Operating Lease Liability To Be Paid Year Four And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter	5095000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9360000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3769000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5591000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4367000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4367000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4367000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3089000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42884000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3848000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4179000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	159000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	218000	usd
	us-gaap	Depreciation Depreciation	493000	usd
	us-gaap	Depreciation Depreciation	760000	usd
CY2024Q3	aqst	Number Of Operating Leases NumberOfOperatingLeases	3	lease
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	457000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1345000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	123000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	349000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	438000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	109000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	317000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1284000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1318000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1346000	usd
CY2024Q3	aqst	Lessee Operating Lease Liability To Be Paid Year Four And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter	5095000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9360000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3769000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5591000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4367000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4367000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3089000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1278000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1278000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	78000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	117000	usd
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	1500000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1200000	usd
CY2024Q3	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	300000	usd
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	300000	usd
CY2024Q3	aqst	Cumulative Royalty Receivable CumulativeRoyaltyReceivable	3000000	usd
CY2023Q4	aqst	Cumulative Royalty Receivable CumulativeRoyaltyReceivable	4000000	usd
CY2024Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1230000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1438000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4230000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5438000	usd
CY2024Q3	aqst	Number Of Guaranteed Royalty Payments NumberOfGuaranteedRoyaltyPayments	8	payment
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	78000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	117000	usd
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	1500000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1200000	usd
CY2024Q3	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	300000	usd
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	300000	usd
CY2024Q3	aqst	Cumulative Royalty Receivable CumulativeRoyaltyReceivable	3000000	usd
CY2023Q4	aqst	Cumulative Royalty Receivable CumulativeRoyaltyReceivable	4000000	usd
CY2024Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1230000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1438000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4230000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5438000	usd
CY2024Q3	aqst	Number Of Guaranteed Royalty Payments NumberOfGuaranteedRoyaltyPayments	8	payment
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3457000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3457000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	473000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	337000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	17000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1013000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	300000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6497000	usd
CY2019Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2000000	shares
CY2019Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2019Q3	aqst	Net Proceeds From Issuance Of Initial Notes Warrants And First Offer Rights NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights	66082000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9540000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	14535000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	20925000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	45000000	usd
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5874000	usd
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4202000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	473000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	17000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1013000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	300000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6497000	usd
CY2019Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2000000	shares
CY2019Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2019Q3	aqst	Net Proceeds From Issuance Of Initial Notes Warrants And First Offer Rights NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights	66082000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9540000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	14535000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	20925000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	45000000	usd
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5874000	usd
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2023Q4	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	64490000	usd
CY2022Q4	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	65259000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	175000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	220000	usd
CY2024Q3	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	1000000	usd
CY2023Q4	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	922000	usd
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2023Q4	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	64490000	usd
CY2022Q4	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	65259000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	175000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	220000	usd
CY2024Q3	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	1000000	usd
CY2023Q4	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	922000	usd
CY2024Q3	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	63730000	usd
CY2023Q3	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	64490000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-11509000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27082000	usd
	us-gaap	Net Income Loss NetIncomeLoss	241000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64678761	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85224263	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59252768	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1547751	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91082081	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64678761	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61513736	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q3	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	63730000	usd
CY2023Q3	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	64490000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-11509000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27082000	usd
	us-gaap	Net Income Loss NetIncomeLoss	241000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91082081	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64678761	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85224263	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59252768	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1547751	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91082081	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64678761	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85224263	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61513736	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1577000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	774000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4696000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1766000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1577000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	774000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4696000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1766000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1577000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1766000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1577000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	774000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4696000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1766000	usd
	aqst	Inducement Equity Common Stock Options Outstanding Shares InducementEquityCommonStockOptionsOutstandingShares	0	shares
CY2023Q4	us-gaap	Share Price SharePrice	4.98
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11509000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27082000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.064
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.374
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-140000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144000	usd
CY2023Q4	us-gaap	Share Price SharePrice	4.98
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11509000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27082000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.064
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.374
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-140000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2175000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	385000	usd
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	385000	usd
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-045030-index-headers.html	Edgar Link	pending
0001628280-24-045030-index.html	Edgar Link	pending
0001628280-24-045030.txt	Edgar Link	pending
0001628280-24-045030-xbrl.zip	Edgar Link	pending
aqst-20240930.htm	Edgar Link	pending
aqst-20240930.xsd	Edgar Link	pending
aquestiveamendedandresta.htm	Edgar Link	pending
aquestiveamendedandresta001.jpg	Edgar Link	pending
aquestiveamendedandresta002.jpg	Edgar Link	pending
aquestiveamendedandresta003.jpg	Edgar Link	pending
aquestiveamendedandresta004.jpg	Edgar Link	pending
aquestiveamendedandresta005.jpg	Edgar Link	pending
aquestiveamendedandresta006.jpg	Edgar Link	pending
aquestiveamendedandresta007.jpg	Edgar Link	pending
aquestiveamendedandresta008.jpg	Edgar Link	pending
aquestiveamendedandresta009.jpg	Edgar Link	pending
aquestiveamendedandresta010.jpg	Edgar Link	pending
aquestiveamendedandresta011.jpg	Edgar Link	pending
aquestiveamendedandresta012.jpg	Edgar Link	pending
aquestiveamendedandresta013.jpg	Edgar Link	pending
aqst-20240930_cal.xml	Edgar Link	unprocessable
aqst-20240930_def.xml	Edgar Link	unprocessable
aqst-20240930_lab.xml	Edgar Link	unprocessable
aqst-20240930_pre.xml	Edgar Link	unprocessable
aqst-20240930_htm.xml	Edgar Link	completed
aquestiveamendedandresta014.jpg	Edgar Link	pending
aquestiveamendedandresta015.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q32024ex311.htm	Edgar Link	pending
q32024ex312.htm	Edgar Link	pending
q32024ex321.htm	Edgar Link	pending
q32024ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQST
Aquestive Therapeutics, Inc. Stock $aqst

2024 Q4 Form 10-Q Financial Statement

#000162828024045030 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQST Aquestive Therapeutics, Inc. Stock $aqst

2024 Q4 Form 10-Q Financial Statement

#000162828024045030 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQST
Aquestive Therapeutics, Inc. Stock $aqst